EyePoint (EYPT) Operating Income Growth (5y) (2015 - 2026)
EyePoint (EYPT) Operating Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,583.17 Bn | 67,582.89 Bn | - |
| 2 | Nanobiotix | 1,947.22 Bn | 1,947.15 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 473.21 Bn | 468.42 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.29 Bn | 116.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - |
| 8 | Argenx Se | 56.63 Bn | 51.45 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.79 Bn | 37.79 Bn | - |
| 10 | EyePoint | 1.10 Mn | -221.44 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.48% |
| Dec 31, 2025 | -40.75% |
| Sep 30, 2025 | -99.62% |
| Jun 30, 2025 | -41.03% |
| Mar 31, 2025 | -33.67% |
| Dec 31, 2024 | -38.17% |
| Sep 30, 2024 | -18.42% |
| Jun 30, 2024 | -27.72% |
| Mar 31, 2024 | -17.86% |
| Dec 31, 2023 | 7.81% |
| Sep 30, 2023 | 12.46% |
| Jun 30, 2023 | -9.50% |
| Mar 31, 2023 | -35.74% |
| Dec 31, 2022 | -49.75% |
| Sep 30, 2022 | -25.09% |
| Jun 30, 2022 | -25.65% |
| Mar 31, 2022 | -28.79% |
| Dec 31, 2021 | -186.20% |
| Sep 30, 2021 | -16.34% |
| Jun 30, 2021 | -11.20% |